-
Functional Dyspepsia Market Analysis And Forecast, 2025-2035, Competitive Analysis Of Astrazeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong
11 Jul 2025 09:39 GMT
… growth. Major players include AstraZeneca and Pfizer, highlighting a … Market Trends Impact Analysis Patent Analysis Patent Filing Trend (by … Country) Patent Filing Trend (by Year … Players and Competition Synopsis AstraZeneca Procter & Gamble …
-
Why IonQ Is My Top Stock Pick For 2025
11 Jul 2025 14:36 GMT
… almost 1000 owned and controlled patents.
AQ is the metric that … , and IonQ’s work with AstraZeneca, AWS and Nvidia cut drug … , networking, satellite and workforce hubs. Patent depth. Customer results. Cash. Its …
-
Creative deal structures help life sciences innovators ride out the macro storm
10 Jul 2025 18:15 GMT
… companies are confronting a patent cliff that is expected … For instance, in 2024 AstraZeneca acquired Amolyt Pharma for USD800m … through the sale of patents, investigational new drug applications … label expansions, and even patent-term-extension events. Deal …
-
CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years
10 Jul 2025 17:59 GMT
… information about clinical trials, the patent landscape, regulatory requirements, and the … INC.
ALLOGENE THERAPEUTICS
AMGEN INC.
ASTRAZENECA
BLUEBIRD BIO INC.
BRISTOL-MYERS … , market share rankings, pipeline and patent analyses, and discussions of key …
-
Europe Pharmaceutical Drugs Market Expands with R&D Innovation, Biologics Growth, and Regulatory Harmonization 2025–2032
10 Jul 2025 08:24 GMT
… 2.8% per annum for patented drugs, influenced by inflation and …
» Sanofi S.A.
» Bayer AG
» AstraZeneca plc
» Novo Nordisk A… due to cost efficiency and patent expiries in 2025 and beyond …
-
Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development
10 Jul 2025 08:00 GMT
… (NASDAQ: KTRA); inventor on 40+ patents; former faculty at Harvard and … CNS Cancer Bioscience Lead at AstraZeneca, where she advanced the development … than 40 scientific publications and patents. “By convening this powerhouse advisory …
-
Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade
09 Jul 2025 17:58 GMT
… respiratory portfolio amid looming Keytruda patent cliff 2025 Johnson & Intra … cs billion antipsychotic medicine as patents on its older therapies near … and Jeff Sagansky 2020 AstraZeneca Alexion $39 AstraZeneca's Pharmaceut billion …
-
Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster Ohtuvayre
09 Jul 2025 19:23 GMT
… for the expected loss of patent protection later this decade for … an eosinophilic phenotype. Amgen and AstraZeneca have hopes for their asthma …
-
Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug
09 Jul 2025 13:20 GMT
… revenue from major drugs losing patent protection.
The FT report states … is set to come off patent and face U.S. government … in sales once Keytruda loses patent protection.
The FT report highlighted … to a July media report, AstraZeneca Plc AZN was reportedly in …
-
Millions still face higher mortgage costs, warns Bank
09 Jul 2025 06:11 GMT
… in 2024 but will see patents start to expire in 2028 … has reacted calmly. Shares in AstraZeneca edged down 0.6 per …
About
© 1995-2025